The biotech company has formed a new senior leadership team to support its strategic and scientific objectives, including experts in drug development, commercial strategy, and manufacturing.
The healthcare company has announced a change in major shareholdings.
The healthcare company has announced a transfer of shares between two of its subsidiaries.
The biotech company has changed its registered address to a new location in London.
The biotech company reports positive results from an in vivo study of its Nuvec delivery system for an inflammatory bowel disease treatment, showcasing the platform's potential.
The healthcare company has announced a change in major shareholding, with Tracarta Limited now holding 18.02% of the voting rights.
The healthcare company has announced changes to its director shareholdings.
The pharmaceutical company has announced a change in its shareholding structure.
The healthcare company has announced a change in shareholding, with Tracarta Limited now holding an 18.02% stake.
The healthcare company has announced a change in its major shareholding structure.